
Atrium Therapeutics, Inc.
NASDAQRNA short interest surged 56.8% over one week to 3.03M shares, driven by a 150.7% monthly jump amid biotech volatility.
Snapshot as of 5 Jul 2026
No long-form analysis yet for RNA. Pulse alerts and the live data picture are available on ORTEX.
Open RNA on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RNA — free to start on ORTEX.
Sign up for free →Open RNA on ORTEX